Trials in Baltimore, Maryland
Here are the top 10 medical studies for prostate cancer in Baltimore, Maryland
Popular Filters
Phase 3 Trials
Radioisotope Therapy
177Lu-PSMA-I&T for Prostate Cancer
Recruiting2 awardsPhase 3
Baltimore, Maryland
This trial is testing a new radioactive drug against standard hormone therapy in men with advanced prostate cancer that doesn't respond to usual treatments. The drug targets and kills cancer cells using radiation. The drug being tested, 225Ac-PSMA-617, has shown promise in inducing complete responses in patients with metastatic castrate-resistant prostate cancer who were resistant to standard therapies.
AKT Inhibitor
Capivasertib + Docetaxel for Prostate Cancer
Recruiting1 awardPhase 3
Baltimore, Maryland
This trial will compare the effect of two different treatments for metastatic prostate cancer. One group will receive a combination of capivasertib and docetaxel, while the other group will receive docetaxel and a placebo. The goal is to see if adding capivasertib to docetaxel improves survival rates.
Hormone Therapy
Relugolix vs Leuprolide for Prostate Cancer
Recruiting2 awardsPhase 3
Washington, District of Columbia
This trial compared the safety and heart-related risks of two hormone-lowering medications, relugolix and leuprolide acetate, in adults with prostate cancer. These drugs help manage cancer by reducing testosterone levels. The study was discontinued, but patients can continue their treatment for a certain period. Relugolix is the first oral medication of its kind and was approved by the FDA based on previous study results.
Trials With No Placebo
Procedure
TULSA Procedure vs. Radical Prostatectomy for Prostate Cancer
Recruiting1 award6 criteria
Baltimore, Maryland
This trial compares a new treatment with traditional surgery in men with prostate cancer. The goal is to see if the new treatment can effectively treat cancer while preserving important functions better than surgery. Patients will be followed for several years to assess outcomes. The new treatment is minimally invasive and uses advanced technology to target prostate tissue.
Monoclonal Antibodies
Vudalimab + Chemotherapy/Targeted Therapy for Prostate Cancer
Recruiting1 awardPhase 2
Philadelphia, Pennsylvania
This trial will study the safety and effectiveness of XmAb20717 as a treatment for patients with metastatic prostate cancer who have been previously treated with other cancer therapies.
Chemotherapy
TT-10 for Advanced Cancer
Recruiting1 awardPhase 1 & 2
Fairfax, Virginia
This trial tests a new oral drug, TT-10, for safety and effectiveness in people with severe cancers that did not improve with usual treatments. The goal is to determine a safe dosage and see if it can help control tumor growth.
Monoclonal Antibodies
XB002 for Advanced Cancers
Recruiting2 awardsPhase 1
Baltimore, Maryland
This trial is testing a new drug called XB002, given through an IV periodically, to see if it can help patients with advanced solid tumors. The drug is tested alone and with other cancer treatments. Researchers are checking if it is safe and effective in shrinking or stopping tumor growth.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.